We are live on ! Find out more
LAB icon

Standard BioTools

100 hedge funds and large institutions have $941M invested in Standard BioTools in 2013 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

85% more capital invested

Capital invested by funds: $509M → $941M (+$431M)

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

32% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $7.66M

16% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 32

12% more funds holding

Funds holding: 89100 (+11)

Holders
100
Holders Change
+11
Holders Change %
+12.36%
% of All Funds
2.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
25
Increased
37
Reduced
32
Closed
14
Calls
$10.1M
Puts
$7.66M
Net Calls
+$2.46M
Net Calls Change
+$2.17M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$1.58M -$720K -24,456 -37%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$1.52M +$1.12M +38,112 +3,465%
EI
53
EAM Investors
California
$1.48M -$369K -12,537 -25%
Group One Trading
54
Group One Trading
Illinois
$1.43M +$1.1M +37,334 +622,233%
U
55
UBS
Switzerland
$1.43M +$928K +31,491 +539%
TA
56
Teachers Advisors
New York
$1.36M +$45.7K +1,550 +5%
NTCOC
57
Northern Trust Company of Connecticut
Connecticut
$1.32M
EIM
58
Essex Investment Management
Massachusetts
$1.25M -$270K -9,161 -22%
NFA
59
Nationwide Fund Advisors
Ohio
$1.2M +$324K +10,998 +54%
TC
60
TFS Capital
Pennsylvania
$1.12M -$1.22M -41,392 -59%
Two Sigma Investments
61
Two Sigma Investments
New York
$1.08M -$2.11M -71,523 -72%
ARTA
62
A.R.T. Advisors
New York
$945K +$728K +24,711 New
Citadel Advisors
63
Citadel Advisors
Florida
$911K +$700K +23,781 New
VOYA Investment Management
64
VOYA Investment Management
Georgia
$893K
Morgan Stanley
65
Morgan Stanley
New York
$882K +$373K +12,652 +122%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$868K +$4.42K +150 +0.7%
MLICM
67
Metropolitan Life Insurance Company (MetLife)
New York
$860K +$102K +3,470 +18%
Wells Fargo
68
Wells Fargo
California
$798K -$4.96M -168,296 -89%
DT
69
Diversified Trust
Tennessee
$790K +$212K +7,210 +54%
DC
70
Deere & Company
Illinois
$779K +$599K +20,340 New
Swiss National Bank
71
Swiss National Bank
Switzerland
$766K -$118K -4,000 -17%
Arrowstreet Capital
72
Arrowstreet Capital
Massachusetts
$710K +$394K +13,384 +261%
AIG
73
American International Group
New York
$669K -$4.98K -169 -1%
BA
74
BlackRock Advisors
Delaware
$646K +$30.5K +1,036 +7%
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$606K

LAB Hedge Fund Activity: Q4 2013 in Review

100 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2013, worth a combined $941M — up 85% from $509M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new LAB positions and 14 closed out — a net gain of 11 holders — while 37 added to existing stakes and 32 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $22M. The largest seller was Jennison Associates, cutting an estimated $20M.

  • 100 institutional investors held Standard BioTools (LAB) as of Q4 2013, up from 89 in Q3 2013.
  • Funds reported $941M of Standard BioTools stock for Q4 2013, up 85% quarter-over-quarter.
  • 25 funds opened new Standard BioTools positions in Q4 2013 and 14 closed out, a net change of +11 holders.
  • The largest Standard BioTools buyer in Q4 2013 was Lord, Abbett & Co, an estimated $22M added.
  • The largest Standard BioTools seller in Q4 2013 was Jennison Associates, an estimated $20M sold.

Based on aggregated 13F filings for Q4 2013.